Responsive brain stimulation could improve life for Parkinson's sufferers

Responsive brain stimulation could improve life for Parkinson’s sufferers
The new system cancels out Parkinson’s-related brainwaves only when needed.

(Medical Xpress)—Researchers in Oxford have demonstrated a significant improvement in the treatment of advanced Parkinson's disease with deep brain stimulation.

Deep brain stimulation involves permanently inserting electrodes into the brain to deliver that cancel out the brain signals causing symptoms of Parkinson's.

The new 'adaptive' system, successfully trialled by a Oxford University team based at the John Radcliffe Hospital, only delivers electrical stimulation when it detects the brainwaves responsible for causing the symptoms.

This is a significant refinement – present systems deliver continuous electrical stimulation to the brain.

The personalised system, which actively detects and responds to a patient's brainwaves using a brain-computer interface, proved more effective than conventional stimulation. By using less than half the power of existing systems, it could also reduce the need for repeat operations to replace batteries.

Deep (DBS) is used to treat the difficulties in moving and involuntary shaking experienced by those living with advanced Parkinson's disease, although it is not suitable for all patients.

Professor Peter Brown of the Nuffield Department of Surgical Sciences at the University of Oxford and consultant neurologist at Oxford's John Radcliffe Hospital, led the study. He said: 'Parkinson's symptoms fluctuate on a moment by moment basis and the activity causing symptoms is not continuous, it comes in bursts. By only delivering stimulation when these bursts are detected, you increase the effectiveness and reduce the amount of electrical stimulation delivered to the brain, reducing .

'DBS treatment is used by Parkinson sufferers for many years. We believe reducing the amount of will lower the risk of side effects, although further research is needed on this aspect.' Potential side effects of can include speech and cognitive deterioration.

His team's proof of concept study is published in the journal Annals of Neurology. The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (a collaboration between Oxford University Hospitals NHS Trust and Oxford University), the Medical Research Council and The Wellcome Trust.

Professor Brown said a major advantage of adaptive DBS was the potential to significantly extend battery life.

He added: 'At present patients need an operation every three or four years to replace the battery. These are elderly patients who are operated on under general anaesthetic. By extending battery life we can reduce the need for these operations.'

The adaptive system was trialled with eight patients. The trial was for 10 minute periods and compared to the effect of no stimulation, constant stimulation and randomised intermittent stimulation.

Professor Brown said: 'We have believed for some time that this could work, but this study has now proved the concept. Our conclusions were backed by independent assessment from experts at University College London.

'However, this was a small-scale proof of concept study. We now need to trial the system for longer periods. For anything longer than a few hours we will need to overcome technological hurdles in terms of miniaturising the system.

'The ultimate goal is a closed loop system small enough to be implanted in the body, similar to conventional DBS systems.'

More information: onlinelibrary.wiley.com/journa… /%28ISSN%291531-8249

Related Stories

Recommended for you

Emotional adjustment following traumatic brain injury

Oct 24, 2014

Life after a traumatic brain injury resulting from a car accident, a bad fall or a neurodegenerative disease changes a person forever. But the injury doesn't solely affect the survivor – the lives of their spouse or partner ...

New ALS associated gene identified using innovative strategy

Oct 22, 2014

Using an innovative exome sequencing strategy, a team of international scientists led by John Landers, PhD, at the University of Massachusetts Medical School has shown that TUBA4A, the gene encoding the Tubulin Alpha 4A protein, ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Woland2244
not rated yet Jul 15, 2013
How could you make a grammar mistake in science artical? Jesus Christ...
On the topic, of course it's useful, but as the article says, it's not a universal method that we are looking for... What a shame...